Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 1
2004 2
2005 3
2006 5
2007 3
2008 1
2009 2
2010 8
2011 3
2012 5
2013 4
2014 6
2015 3
2016 4
2017 9
2018 7
2019 9
2020 5
2021 9
2022 3
2023 6
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

92 results

Results by year

Filters applied: . Clear all
Page 1
Specific imaging of CD8 + T-Cell dynamics with a nanobody radiotracer against human CD8β.
De Groof TWM, Lauwers Y, De Pauw T, Saxena M, Vincke C, Van Craenenbroeck J, Chapon C, Le Grand R, Raes G, Naninck T, Van Ginderachter JA, Devoogdt N. De Groof TWM, et al. Among authors: raes g. Eur J Nucl Med Mol Imaging. 2024 Dec;52(1):193-207. doi: 10.1007/s00259-024-06896-3. Epub 2024 Sep 2. Eur J Nucl Med Mol Imaging. 2024. PMID: 39218831 Free PMC article.
Current status and future expectations of nanobodies in oncology trials.
De Pauw T, De Mey L, Debacker JM, Raes G, Van Ginderachter JA, De Groof TWM, Devoogdt N. De Pauw T, et al. Among authors: raes g. Expert Opin Investig Drugs. 2023 Jul-Dec;32(8):705-721. doi: 10.1080/13543784.2023.2249814. Epub 2023 Aug 28. Expert Opin Investig Drugs. 2023. PMID: 37638538 Review.
Phase I Study of [68Ga]Ga-Anti-CD206-sdAb for PET/CT Assessment of Protumorigenic Macrophage Presence in Solid Tumors (MMR Phase I).
Gondry O, Xavier C, Raes L, Heemskerk J, Devoogdt N, Everaert H, Breckpot K, Lecocq Q, Decoster L, Fontaine C, Schallier D, Aspeslagh S, Vaneycken I, Raes G, Van Ginderachter JA, Lahoutte T, Caveliers V, Keyaerts M. Gondry O, et al. Among authors: raes g. J Nucl Med. 2023 Sep;64(9):1378-1384. doi: 10.2967/jnumed.122.264853. Epub 2023 Jul 20. J Nucl Med. 2023. PMID: 37474271 Free PMC article. Clinical Trial.
A few good reasons to use nanobodies for cancer treatment.
Jumapili NA, Zivalj M, Barthelmess RM, Raes G, De Groof TWM, Devoogdt N, Stijlemans B, Vincke C, Van Ginderachter JA. Jumapili NA, et al. Among authors: raes g. Eur J Immunol. 2023 Sep;53(9):e2250024. doi: 10.1002/eji.202250024. Epub 2023 Jun 27. Eur J Immunol. 2023. PMID: 37366246 Free article. Review.
Applications of nanobodies in brain diseases.
Zheng F, Pang Y, Li L, Pang Y, Zhang J, Wang X, Raes G. Zheng F, et al. Among authors: raes g. Front Immunol. 2022 Nov 8;13:978513. doi: 10.3389/fimmu.2022.978513. eCollection 2022. Front Immunol. 2022. PMID: 36426363 Free PMC article. Review.
In vivo Visualization of M2 Macrophages in the Myocardium After Myocardial Infarction (MI) Using 68 Ga-NOTA-Anti-MMR Nb: Targeting Mannose Receptor (MR, CD206) on M2 Macrophages.
Varasteh Z, Braeuer M, Mohanta S, Steinsiek AL, Habenicht A, Omidvari N, Topping GJ, Rischpler C, Weber WA, Sager HB, Raes G, Hernot S, Schwaiger M. Varasteh Z, et al. Among authors: raes g. Front Cardiovasc Med. 2022 Apr 25;9:889963. doi: 10.3389/fcvm.2022.889963. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35548425 Free PMC article.
92 results